Skip to main content

SpaA Updates: Anti-infliximab Antibodies, Difficult to Treat AxSpa

Dr. Eric Dein (Jersey City, New Jersey) reports on abstracts 2546 and 2547, presented at the 2023 ACR Convergence meeting in San Diego, CA.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×